Petros Fessas

6PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 19, 2025
Pathological complete response with cocktail chemotherapy in mediastinal seminoma.

Petros Fessas, Linda Charalambous, Sarah Morgan

|Oct 01, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.

David J Pinato, Sam M Murray, Alejandro Forner

|Oct 08, 2020
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.

David J Pinato, Ahmed Kaseb, Yinghong Wang

|Sep 02, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.

Petros Fessas, Ahmed Kaseb, Yinghong Wang

|Oct 25, 2019
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms.

Petros Fessas, Lucia A Possamai, James Clark

|Aug 15, 2018
Question 1: Is there a role for the ketogenic diet in refractory status epilepticus?

Petros Fessas, Amedine Duret

Pageof 1

Frequent Collaborators

2 joint publications

Yinghong Wang

2 joint publications

Yi-Hsiang Huang

2 joint publications

David J Pinato

1 joint publications

Amedine Duret